Nat. Rev. Nephrol. doi: /nrneph

Slides:

Advertisements

Similar presentations

Volume 74, Issue 2, Pages (July 2008)

Advertisements

Figure 1 Schematic representation of idiopathic nephrotic syndrome,

Urinary system imaging

Nat. Rev. Nephrol. doi: /nrneph

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 4 Interplay between acute kidney injury (AKI),

Figure 6 Effects of adiponectin on podocyte function

Figure 6 Differences in glycaemic control with the study drug

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Interactions between adipose, the microbiome and kidney

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 2 Physiological changes in the renal system in pregnancy

Figure 1 Types of coronary artery calcification

Figure 2 Proinflammatory mechanisms in CKD

Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Model of mechanosensation through primary cilia

Nat. Rev. Nephrol. doi: /nrneph

Figure 7 Overview of crystal deposition in the

Figure 6 Tissular changes in crystalline CKD

Nat. Rev. Nephrol. doi: /nrneph

Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.

Figure 7 The efficacy of phosphate-binder therapy

CT Urography for the Diagnosis of Medullary Sponge Kidney

Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

A. Evan, J. Lingeman, F.L. Coe, E. Worcester Kidney International

Volume 67, Issue 2, Pages (February 2005)

Figure 2 Expression of complement activation products in renal samples

Figure 5 Risk factor control in the intensive treatment group

Figure 2 The network of chronic diseases and their mutual influences

Figure 1 The burden of chronic kidney disease (CKD)

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Societal costs for the care of patients with chronic kidney disease in the UK Figure 3 | Societal costs for the care of patients with chronic.

Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.

Figure 2 Podocyte dysfunction is a common feature of renal injury

Volume 78, Issue 3, Pages (August 2010)

Volume 74, Issue 2, Pages (July 2008)

Figure 1 Acute kidney injury and chronic kidney disease

Figure 2 The continuum of acute kidney injury (AKI),

Nat. Rev. Urol. doi: /nrurol

Update on Nephrolithiasis: Core Curriculum 2016

Figure 4 Model of changes in the serum levels

Volume 69, Issue 12, Pages (June 2006)

Nat. Rev. Nephrol. doi: /nrneph

Figure 6 Image sequence demonstrating coronal cuts on MRI

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Localization of ErbB receptors and ligands within the nephron

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Hypothetical trajectories of acute kidney disease (AKD)

Volume 76, Issue 10, Pages (November 2009)

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Serum phosphate level is associated with

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)

Nat. Rev. Nephrol. doi: /nrneph

The missing medullary sponge kidney

Nat. Rev. Nephrol. doi: /nrneph

Axial computed tomography (CT) images a) at baseline and b) at a 12-month follow-up scan, in a patient with idiopathic pulmonary fibrosis (IPF). b) Note.

Figure 1 Patient, facility, health-care system and industry factors

Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)

Figure 1 Worldwide distribution of disease burden attributable to environmental risks in 2012 Figure 1 | Worldwide distribution of disease burden attributable.

Volume 68, Issue 1, Pages (July 2005)

Nat. Rev. Nephrol. doi: /nrneph

Figure 16c. Determination of chemical composition of renal stones in two different patients who presented with flank pain. (a, b) Axial dual-source DEdual-energy.

Presentation transcript:

Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.101 Figure 3 Bellini duct plugs with overgrowths in patients who formed calcium stones Figure 3 | Bellini duct plugs with overgrowths in patients who formed calcium stones. a | Sites of crystalline deposits that form plugged Bellini ducts with an overgrowth region protruding into the urinary space. b | Endoscopic image of a plug (large arrow) protruding from a dilated Bellini duct (small arrows). Bellini duct plugs with overgrowths visible by light microscopy and micro-CT from c | a patient with idiopathic hydroxyapatite stones, d | a patient with idiopathic brushite stones, e | a patient with ileostomy, f | a patient with primary hyperparathyroidism, and g | a medullary sponge kidney. The curved, dotted lines divide the plugs from the overgrowth regions. Coe, F. L. et al. (2016) Idiopathic hypercalciuria and formation of calcium renal stones Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.101